Lisanti Capital Growth, LLC Insulet Corp Transaction History

Lisanti Capital Growth, LLC

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 03, 2023	BUY	$212.22 - $313.46 $1.38 Million - $2.05 Million	6,525 Added 47.08%	20,385 $6 Million
Q3 2022 Nov 01, 2022	BUY	$224.6 - $281.45 $3.11 Million - $3.9 Million	13,860 New	13,860 $3.18 Million
Q2 2020 Aug 10, 2020	SELL	$159.17 - $224.73 $1.78 Million - $2.52 Million	-11,212 Closed	0 $0
Q1 2020 May 11, 2020	SELL	$130.01 - $216.44 $503,658 - $838,488	-3,874 Reduced 25.68%	11,212 $1.86 Million
Q4 2019 Feb 13, 2020	SELL	$144.81 - $186.0 $88,913 - $114,204	-614 Reduced 3.91%	15,086 $2.58 Million
Q3 2019 Nov 06, 2019	BUY	$117.35 - $167.95 $154,902 - $221,693	1,320 Added 9.18%	15,700 $2.59 Million
Q2 2019 Aug 05, 2019	SELL	$82.13 - $120.73 $251,728 - $370,037	-3,065 Reduced 17.57%	14,380 $1.72 Million
Q1 2019 May 13, 2019	BUY	$72.44 - $101.87 $129,305 - $181,837	1,785 Added 11.4%	17,445 $1.66 Million
Q4 2018 Feb 08, 2019	BUY	$73.27 - $105.19 $670,054 - $961,962	9,145 Added 140.37%	15,660 $1.24 Million
Q3 2018 Nov 05, 2018	SELL	$81.43 - $108.13 $3.55 Million - $4.72 Million	-43,645 Reduced 87.01%	6,515 $690,000
Q2 2018 Aug 13, 2018	SELL	$83.27 - $101.93 $1.11 Million - $1.36 Million	-13,300 Reduced 20.96%	50,160 $4.3 Million
Q1 2018 May 15, 2018	BUY	$68.49 - $87.2 $1.17 Million - $1.48 Million	17,020 Added 36.65%	63,460 $5.5 Million
Q4 2017 Feb 07, 2018	BUY	$55.67 - $71.8 $780,771 - $1.01 Million	14,025 Added 43.27%	46,440 $3.2 Million
Q3 2017 Nov 13, 2017	BUY	$49.68 - $59.46 $1.61 Million - $1.93 Million	32,415	32,415 $1.79 Million

723

63.3M

640K

858K

Ticker PODD
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 69,403,600
Market Cap $19.6B
Description
Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes. It offers Omnipod System, a self-adhesive disposable tubeless Omnipod device that is worn on the body for up to three days at a time, as well as its wireless companion, the handheld personal diabetes manager. The company sel...

Get notified when there are updates to the investment portfolio of Lisanti Capital Growth, LLC, based on Form 13F filings with the SEC.

Stay updated on Lisanti Capital Growth, LLC with notifications on news.